These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 191950)

  • 41. Lipid metabolism in human platelets.
    Majerus PW; Baenziger NL; Brodie GN
    Ser Haematol; 1971; 4(1):59-74. PubMed ID: 5117886
    [No Abstract]   [Full Text] [Related]  

  • 42. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
    Holmbeg L; Nilsson IM
    Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
    Ryningen A; Olav Jensen B; Holmsen H
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
    Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creatine phosphate in rat platelets decreased by ADP or thrombin.
    Shibata S
    Thromb Haemost; 1979 Aug; 42(2):626-30. PubMed ID: 505370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
    Kaur H; Corscadden K; Ware J; Othman M
    Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipid-deacylating enzymes of rabbit platelets.
    Kannagi R; Koizumi K
    Arch Biochem Biophys; 1979 Sep; 196(2):534-42. PubMed ID: 225999
    [No Abstract]   [Full Text] [Related]  

  • 49. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE; Srivastava PC; Mills DC
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Von Willebrand's disease in Italy. A study of 13 families from a small area in the province of Vicenza.
    Dini E; Barbui T; Chisesi T; Cazzavillan M; Battista R; Cartei G
    Acta Haematol; 1974; 52(1):29-39. PubMed ID: 4212516
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets.
    Brodie GN; Baenziger NL; Chase LR; Majerus PW
    J Clin Invest; 1972 Jan; 51(1):81-8. PubMed ID: 4331802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of adenosine 5'-diphosphate and shape change on 5-hydroxytryptamine uptake by human blood platelets.
    Frojmovic MM; Rotman A
    Thromb Res; 1980 Feb 1-15; 17(3-4):507-17. PubMed ID: 6245479
    [No Abstract]   [Full Text] [Related]  

  • 53. Von Willebrand's syndrome.
    Mannucci PM
    Recent Results Cancer Res; 1979; 69():125-36. PubMed ID: 382305
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombin-induced lysosomal exocytosis in human platelets is dependent on secondary activation by ADP and regulated by endothelial-derived substances.
    Södergren AL; Svensson Holm AC; Ramström S; Lindström EG; Grenegård M; Öllinger K
    Platelets; 2016; 27(1):86-92. PubMed ID: 25970449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.
    Zavoico GB; Feinstein MB
    Biochem Biophys Res Commun; 1984 Apr; 120(2):579-85. PubMed ID: 6329175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 58. Endogenous ADP prevents PGE1-induced tyrosine dephosphorylation of focal adhesion kinase in thrombin-activated platelets.
    Vostal JG; Shafer B; Mondoro TH; Fratantoni JC
    Biochim Biophys Acta; 1996 Nov; 1314(1-2):1-12. PubMed ID: 8972712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.
    Lips JP; Sixma JJ; Schiphorst ME
    Biochim Biophys Acta; 1980 Apr; 628(4):451-67. PubMed ID: 6245712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.